Cytokinetics, Inc. (CYTK)
61.95
-1.97
(-3.08%)
USD |
NASDAQ |
Oct 16, 16:00
61.97
+0.02
(+0.03%)
After-Hours: 20:00
Cytokinetics Net Income (TTM) : -894.00M for June 30, 2026
Net Income (TTM) Chart
Historical Net Income (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -894.00M |
| March 31, 2026 | -829.61M |
| December 31, 2025 | -784.96M |
| September 30, 2025 | -751.94M |
| June 30, 2025 | -606.31M |
| March 31, 2025 | -615.26M |
| December 31, 2024 | -589.53M |
| September 30, 2024 | -576.40M |
| June 30, 2024 | -545.28M |
| March 31, 2024 | -530.60M |
| December 31, 2023 | -526.24M |
| September 30, 2023 | -526.73M |
| June 30, 2023 | -539.62M |
| March 31, 2023 | -430.80M |
| December 31, 2022 | -388.96M |
| September 30, 2022 | -282.14M |
| June 30, 2022 | -215.92M |
| March 31, 2022 | -257.66M |
| December 31, 2021 | -215.31M |
| September 30, 2021 | -228.67M |
| June 30, 2021 | -155.76M |
| March 31, 2021 | -134.99M |
| December 31, 2020 | -127.29M |
| September 30, 2020 | -114.00M |
| June 30, 2020 | -140.40M |
| Date | Value |
|---|---|
| March 31, 2020 | -131.73M |
| December 31, 2019 | -121.69M |
| September 30, 2019 | -117.52M |
| June 30, 2019 | -109.96M |
| March 31, 2019 | -105.38M |
| December 31, 2018 | -106.29M |
| September 30, 2018 | -120.30M |
| June 30, 2018 | -130.64M |
| March 31, 2018 | -132.20M |
| December 31, 2017 | -127.79M |
| September 30, 2017 | -80.15M |
| June 30, 2017 | -14.43M |
| March 31, 2017 | 3.041M |
| December 31, 2016 | 16.45M |
| September 30, 2016 | 0.067M |
| June 30, 2016 | -42.14M |
| March 31, 2016 | -41.08M |
| December 31, 2015 | -37.50M |
| September 30, 2015 | -19.83M |
| June 30, 2015 | -16.95M |
| March 31, 2015 | -14.77M |
| December 31, 2014 | -14.65M |
| September 30, 2014 | -16.56M |
| June 30, 2014 | -23.18M |
| March 31, 2014 | -29.84M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (TTM) Benchmarks
| Bristol Myers Squibb Co. | 9.275B |
| Alnylam Pharmaceuticals, Inc. | 807.99M |
| BioMarin Pharmaceutical, Inc. | 72.97M |
| Exelixis, Inc. | 860.62M |
| Ionis Pharmaceuticals, Inc. | -564.78M |